CG MedTech Co.,Ltd. (KOSDAQ:056090)
1,165.00
+26.00 (2.28%)
At close: Sep 4, 2026
CG MedTech Revenue
CG MedTech had revenue of 15.32B KRW in the quarter ending June 30, 2026, with 21.26% growth. This brings the company's revenue in the last twelve months to 51.20B, up 19.80% year-over-year. In the year 2025, CG MedTech had annual revenue of 47.23B with 36.43% growth.
Revenue (ttm)
51.20B
Revenue Growth
+19.80%
P/S Ratio
2.35
Revenue / Employee
426.66M
Employees
120
Market Cap
120.30B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 47.23B | 12.61B | 36.43% |
| Dec 31, 2024 | 34.62B | -345.79M | -0.99% |
| Dec 31, 2023 | 34.97B | -6.20B | -15.06% |
| Dec 31, 2022 | 41.17B | 3.11B | 8.18% |
| Dec 31, 2021 | 38.06B | 10.28B | 37.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| KM Corporation | 144.10B |
| JW Shinyak | 81.04B |
| Sewoon Medical | 66.53B |
| OSTEONIC | 50.97B |
| DuChemBIO | 41.51B |
| Wonbiogen | 37.80B |
| SCL Science | 30.50B |
| Plasmapp | 12.02B |